The program of renal fibrogenesis is controlled by microRNAs regulating oxidative metabolism

Autor: Diego Rodríguez-Puyol, Laura García-Bermejo, Ricardo Luiz Ramos, Santiago Lamas, Verónica Miguel
Přispěvatelé: Ministerio de Ciencia e Innovación (España), Instituto de Salud Carlos III, Comunidad de Madrid, Sociedad Española de Nefrología, Fundación Renal Íñigo Álvarez de Toledo, Fundación Ramón Areces
Rok vydání: 2020
Předmět:
0301 basic medicine
MMP
mitochondrial membrane potential

Clinical Biochemistry
Eto
etomoxir

Mitochondrion
Kidney
Biochemistry
CPT1A
0302 clinical medicine
Fibrosis
OCR
oxygen consumption rate

Beta oxidation
lcsh:QH301-705.5
lcsh:R5-920
TFAM
mitochondrial transcription factor A

Extracellular matrix
ECM
extracellular matrix

Mitochondria
medicine.anatomical_structure
Fatty acid oxidation
lcsh:Medicine (General)
Myofibroblast
Research Paper
Ureteral Obstruction
ITS
insulin-transferrin-selenium

FDR
false discovery rate

Fatty acid oxidation Extracellular matrix
ETC
electron transport chain

Biology
AKI
acute kidney injury

SPF
specific pathogen free

Nephropathy
Transforming Growth Factor beta1
03 medical and health sciences
MicroRNAS
Kidney fibrosis
FBS
fetal bovine serum

TGF-β
transforming growth factor-β

medicine
Renal fibrosis
miRNAs
microRNAs

Humans
UUO
unilateral ureteral obstruction

ECAR
extracellular acidification rate

Organic Chemistry
CKD
chronic kidney disease

TFAM
medicine.disease
Oxidative Stress
030104 developmental biology
lcsh:Biology (General)
Cancer research
FAN
folic acid nephropathy

030217 neurology & neurosurgery
FAO
fatty acid oxidation

EMT
epithelial-to-mesenchymal transition
Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
instname
Redox Biology
Redox Biology, Vol 40, Iss, Pp 101851-(2021)
Popis: Excessive accumulation of extracellular matrix (ECM) is the hallmark of fibrotic diseases. In the kidney, it is the final common pathway of prevalent diseases, leading to chronic renal failure. While cytokines such as TGF-β play a fundamental role in myofibroblast transformation, recent work has shown that mitochondrial dysfunction and defective fatty acid oxidation (FAO), which compromise the main source of energy for renal tubular epithelial cells, have been proposed to be fundamental contributors to the development and progression of kidney fibrosis. MicroRNAs (miRNAs), which regulate gene expression post-transcriptionally, have been reported to control renal fibrogenesis. To identify miRNAs involved in the metabolic derangement of renal fibrosis, we performed a miRNA array screen in the mouse model of unilateral ureteral obstruction (UUO). MiR-150-5p and miR-495-3p were selected for their link to human pathology, their role in mitochondrial metabolism and their targeting of the fatty acid shuttling enzyme CPT1A. We found a 2- and 4-fold upregulation of miR-150-5p and miR-495-5p, respectively, in both the UUO and the folic acid induced nephropathy (FAN) models, while TGF-β1 upregulated their expressions in the human renal tubular epithelial cell line HKC-8. These miRNAs synergized with TGF-β regarding its pro-fibrotic effect by enhancing the fibrosis-associated markers Acta2, Col1α1 and Fn1. Bioenergetics studies showed a reduction of FAO-associated oxygen consumption rate (OCR) in HKC-8 cells in the presence of both miRNAs. Consistently, expression levels of their mitochondrial-related target genes CPT1A, PGC1α and the mitochondrial transcription factor A (TFAM), were reduced by half in renal epithelial cells exposed to these miRNAs. By contrast, we did not detect changes in mitochondrial mass and transmembrane potential (ΔѰm) or mitochondrial superoxide radical anion production. Our data support that miR-150 and miR-495 may contribute to renal fibrogenesis by aggravating the metabolic failure critically involved in tubular epithelial cells, ultimately leading to fibrosis.
Graphical abstract MiR-150-5p and miR-495-3p exert pro-fibrotic effects by synergizing with TGF-β in the fibrotic response and contributing to the mitochondrial impairment associated to renal fibrosis.Image 1
Highlights • MiR-150-5p and miR-495-3p were upregulated both in the UUO and FAN models. • MiR-150-5p and miR-495-3p synergized with TGF-β profibrotic effects and reduced FAO-associated OCR in renal epithelial cells. • MiR-150-5p and miR-495-3p did not alter mitochondrial transmembrane potential and superoxide radical anion production. • MiRNAs 150-5p and 495-3p are contributors to the metabolic impairment leading to renal fibrosis.
Databáze: OpenAIRE